ADMA News and Press, ADMA Biologics Inc From 08/05/20

ADMA Biologics, Inc. (ADMA) Q2 2020 Results Earnings Conference Call August 5, 2020, 04:30 PM ET Company Participants Michelle Pappanastos - Investor Relations, Argot Partners Adam Grossman - Founder, President and Chief Executive Officer Brian Lenz - Executive Vice President and...

ADMA Biologics (NASDAQ: ADMA ) : Q2 GAAP EPS of -$0.23 misses by $0.07 . More news on: ADMA Biologics, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Generated Total Revenues of $18.0 Million for the First Half of 2020, Reflecting a 78% Increase Over First Half of 2019 Joined CoVIg-19 Plasma Alliance and Successfully Opened New ADMA BioCenters Plasma Collection Center Company Anticipates Generating $250 Million or More in Annua...

Penny Stocks Are Surging & So Are COVID Cases; 4 Names To Know This week, penny stocks as well as new coronavirus cases are surging. In the U.S. alone, more than 4.5 million confirmed cases were recorded in total. More than 150,000 deaths have also been counted. Over the past week, the a...

FSD Pharma (NASDAQ: HUGE ) +130% . on decision to surrender health Canada licenses for subsidiary FV Pharma. More news on: FSD Pharma Inc., Kandi Technologies Group, Inc., Edesa Biotech, Inc., Stocks on the move, , Read more ...

Will These Penny Stocks Stay Below $4.50? Are penny stocks part of your trading strategy right now? With so many options available like crypto, options, futures, and, of course, blue-chip socks , it can be something to consider. However, not all penny stocks are “good for your heal...

RAMSEY, N.J. and BOCA RATON, Fla., July 29, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced the Co...

RAMSEY, N.J. and BOCA RATON, Fla. and KNOXVILLE, Tenn., July 06, 2020 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, t...

Ultra-thinly traded micro cap Liminal BioSciences ( LMNL +129.1% ) is up on a whopping 105x surge in volume, albeit on a relatively modest 1.2M shares, in reaction to its announcement that subsidiary Prometic Plasma Resources has started collecting convalescent plasma from people who hav...

In today's market, it is easy to overlook a stock like ADMA Biologics ( ADMA ), which has barely moved even as the market has continued to shoot up. However, despite its boring appearance, ADMA actually has a really compelling "high probability" bull case that should play out over the next 1-2...